Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Inetetamab, a monoclonal antibody, targets domain IV of the HER2 receptor and demonstrates antitumor activities both as a standalone therapy and when combined with tyrosine kinase inhibitors [1] [2]. |
In vivo | Inetetamab administered at a dose of 20 mg/kg via intraperitoneal injection demonstrated antitumor activity in the JIMT-1 xenograft mouse model [2]. When combined with either Pyrotinib or Cyclophosphamide, Inetetamab also exhibited significant antitumor effects in both JIMT-1 and NCI-N87 xenograft mouse models [2]. |
Cas No. |
Storage |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.